Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
02/2009
02/19/2009WO2009021944A1 New compounds
02/19/2009WO2008148057A3 Cationic lipids compositions and methods for enhancing immune responses to vaccines
02/19/2009US20090048372 Protective barrier composition comprising reaction of phosphorous acid with amines applied to a substrate
02/19/2009US20090048255 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs
02/19/2009US20090048224 Compounds and methods of use
02/19/2009CA2696556A1 New compounds
02/19/2009CA2696261A1 New compounds
02/19/2009CA2695636A1 Bicyclic acylguanidine derivative
02/18/2009EP2025673A1 Arylsulfonamides with analgetic activity
02/18/2009EP2024359A1 Compounds that are agonists of muscarinic receptors and that may be effective in treating pain, alzheimer's decease and/or schizophrenia
02/18/2009EP2024350A1 Piperidine derivatives as human papilloma virus inhibitors
02/18/2009EP1641775B1 2-pyridine alkyne derivatives useful for treating pain
02/18/2009EP1399431B1 Novel nitriles useful as reversible inhibitors of cysteine proteases
02/18/2009CN101370779A Cyclohexyl sulfonamide derivatives having H3 receptor activity
02/18/2009CN101370773A Cycloalkanecarboxamide derivative and method for producing same
02/17/2009US7491821 2-(4-fluorophenyl)-4-propyl-oxazole-5-carboxylic acid {2-[4-(6-aminopyridin-2-yl)-piperazin-1-yl]-1-methyl-ethyl}amide; purinergic receptor antagonists, analgesics; urogenital, gastointestinal and respiratory system disorders
02/17/2009US7491741 Diaminopropionic acid derivatives
02/17/2009US7491727 Arylpiperazinyl compounds
02/17/2009US7491723 Alkanol and cycloalkanol-amine derivatives and methods of their use
02/17/2009US7491705 ((1S)-1-((((1S)-1-benzyl-2,3-dioxo-3-(cyclopropylamino)propyl)amino)carbonyl)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester; ischemic disease, immunologic disease, multiple sclerosis, Alzheimer's disease, osteoporosis, diseases caused by brain tissue damage, cataract, glaucoma
02/17/2009CA2157143C Alkylbenzoylguanidine derivatives
02/12/2009WO2009020198A1 Aniline derivative having anti-dna virus activity
02/12/2009WO2008139481A3 Proton acceptor iminium/carbocation-type coupling agents
02/12/2009WO2008104582A3 Novel method for producing teta by means of eddn
02/12/2009US20090043094 Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives
02/12/2009US20090042981 FDA Orange book listed patent for fesoterodine fumarate; urinary incontinence; isobutyric acid 2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethylphenyl ester is fesoteridine
02/12/2009US20090042929 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors
02/12/2009US20090042920 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
02/12/2009US20090042907 Bicyclic aromatic sulfinyl derivatives
02/12/2009US20090042899 Piperazinyl-or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase
02/12/2009US20090042886 Benzamide Inhibitors of the P2X7 Receptor
02/12/2009US20090042855 BENZAMIDE mGluR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME
02/12/2009US20090041663 Sigma-2 receptor radiotracers for imaging the proliferative status of solid tumors
02/11/2009CN101362738A Method for preparing cinepazide maleate
02/10/2009US7488844 Therapeutic agents
02/10/2009US7488731 Arylpiperazinyl compounds
02/10/2009US7488730 N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-phenyl-1-piperazinealkylamide derivatives, and therapeutic use thereof as 5-HT7 receptor ligands
02/10/2009CA2349452C Therapeutic agents for drug dependence
02/10/2009CA2336691C Ligands for metals and metal-catalyzed processes
02/10/2009CA2328396C New substituted amides, their production and their use
02/05/2009WO2009016414A1 Novel process
02/05/2009WO2009016286A2 6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof
02/05/2009WO2009016085A1 Spiro compounds useful as antagonists of the h1 receptor
02/05/2009WO2008150486A3 2-acylaminopropoanol-type glucosylceramide synthase inhibitors
02/05/2009US20090036450 Pyrazole compounds and use thereof
02/05/2009US20090036444 5-5-Membered fused heterocyclic compound and use thereof as HCV polymerase inhibitor
02/05/2009US20090036436 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity
02/05/2009US20090036419 Compounds useful as raf kinase inhibitors
02/05/2009DE19963179B4 Substituierte 1- und 2-Naphthol-Mannichbasen Substituted 1- and 2-naphthol Mannich bases
02/05/2009CA2694608A1 A process for the preparation of almotriptan and a synthetic intermediate usable in said process
02/05/2009CA2691866A1 6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof
02/04/2009EP1565422B1 Vitamin d receptor modulators
02/04/2009CN101360728A Iap bir domain binding compounds
02/04/2009CN101360727A Process for the preparation of a pharmaceutical intermediate
02/04/2009CN101360726A Method for producing tertiary amine
02/04/2009CN101360706A (R)-arylalkylamino derivatives and pharmaceutical compositions containing them
02/04/2009CN100457738C Aryloxyphenyl and arylsulfanylphenyl piperazine derivatives
02/04/2009CN100457726C Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obestity and type II diabetes
02/03/2009US7485651 Cholinergic agents such as 4-Butyl-1-(4-phenyl-4-oxo-1-butyl) piperidine, administered as cognition activators and for prophylaxis of vision defects
02/03/2009US7485644 hydroxy{(1S)-4-pyrimidin-2-yl-1-[({4-[5-(2,2,2-trifluoroethoxy)pyrimidin-2-yl]piperazin-1-yl}sulfonyl)methyl]butyl}formamide; collagenase 3 inhibitor; tissue remodelling such as embryonic development, bone formation and uterine remodelling during menstruation
02/03/2009US7485631 macrolactone antibiotics; Phorboxazole mimetics; carcinogenic agent; cancer cell division inhibitor; pancreatic, breast, non-small lung, colon, and prostate cancers, leukemia
02/03/2009CA2259936C Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents
01/2009
01/29/2009WO2009013915A1 Inhibitor of plasminogen activator inhibitor-1
01/29/2009WO2007144769A8 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
01/29/2009US20090030197 Quinoline Intermediates of Receptor Tyrosine Kinase Inhibitors and the Synthesis Thereof
01/29/2009US20090029999 Synephrine derivatives useful as anti-inflammatory agents
01/29/2009US20090029995 Hetero biaryl derivatives as matrix metalloproteinase inhibitors
01/29/2009US20090029991 Benzamide derivatives useful as histone deacetylase inhibitors
01/29/2009US20090029985 Pyridazine compounds and methods
01/29/2009US20090029858 Spirocyclic 3'-Alkoxytetramic Acids and -Tetronic Acids
01/29/2009CA2694224A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
01/28/2009EP2019097A1 Process for preparing (alphaS)-alpha-(2-methylpropyl)-2-(1-piperidinyl)benzenemethanamine
01/28/2009EP2019096A1 Process for obtaining Cetirizine dihydrochloride
01/28/2009EP1670761B1 Tetrahydro-naphthalene and urea derivatives
01/28/2009EP1542687B1 Small organic molecules that increase the activity of gelatinase a in ocular cells
01/28/2009CN101356164A Novel compounds
01/28/2009CN101356163A Sulfanyl substituted phenyl methanones as glycine transporter 1 (GlyT-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
01/28/2009CN101356162A Optically active carbamates, process for preparation thereof and use thereof as pharmaceutical intermediates
01/28/2009CN101356149A Indene derivatives, their preparation and use as medicaments
01/28/2009CN101353321A 3-amino-piperadine derivatives and methods of manufacture
01/28/2009CN101353313A Process to produce oxazolidinones
01/28/2009CN100455566C Novel derivatives of aminocyclohexane
01/28/2009CN100455565C Sulfonamide anions as catalysts for nco oligomerization
01/27/2009US7482462 Immunosuppressants for treating skin disorders, acne, alopecia, estrogen- or androgen-dependent tumors, rheumatoid arthritis, type I and II diabetes, lupus erythematosus, multiple sclerosis, ulcerative colitis, Crohn's disease, psoriasis, contact dermatitis, graft versus host disease, eczema, asthma
01/27/2009US7482448 Compounds and compositions as cathepsin inhibitors
01/27/2009US7482364 Histamine H3 antagonists; do not contain imidazolyl moiety; such as 1-[4-(4-piperidin-1-ylmethyl-phenyl)-but-3-ynyl]-piperidine
01/27/2009US7482346 Carboxylation of the alkylpiperazine; amidation of the carbamate-ester; cannabinoid and vanilloid receptor antagonists
01/27/2009US7482022 Palatable chewable tablet
01/27/2009CA2247443C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma
01/22/2009WO2009012201A2 Process for the preparation of trifluoroalkyl-phenyl and heterocyclic sulfonamides
01/22/2009WO2009010522A1 Aldimines and compositions comprising aldamine
01/22/2009US20090023917 Selective Estrogen Receptor Modulators for the Treatment of Vasomotor Symptoms
01/22/2009US20090023750 Novel salts of piperazine compounds as d3/d2 antagonists
01/22/2009US20090023747 Cysteine Protease Inhibitors
01/22/2009US20090023735 Sulphonamide Derivatives
01/22/2009US20090023734 Treating cell proliferative disorders
01/22/2009US20090023730 such as 1-(3-tert-butyl-1-methyl-1H-pyrazole-5-carbonyl)-3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thiourea; packages, patches; hepatitis virus infections
01/22/2009US20090023664 protease inhibitors such as 5-(dimethylamino)-N-[(2S,3R)-3-hydroxy-4-[(4-methoxyphenyl)sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-2-methylbenzamide, used for for treating human immunodeficiency virus (HIV) infections
01/22/2009DE102008002923A1 Verfahren zur Hestellung von tertiären Alkylestern der(Meth)Acrylsäure mit mindestens 4 Kohlenstoffatomen im Alkylrest A process for the operations department of tertiary alkyl esters of (meth) acrylic acid having at least 4 carbon atoms in the alkyl radical
01/21/2009EP2017260A1 Aldimines and compounds containing aldimine
1 ... 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 ... 341